ACOTEC-B (06669): Venous Intracavitary Radiofrequency Ablation System Receives FDA 510(K) Market Clearance

Stock News
2025/10/09

ACOTEC-B (06669) announced that on October 7, 2025, the company's venous intracavitary radiofrequency ablation system received 510(k) market clearance from the U.S. Food and Drug Administration. The system includes the Cedar™ venous intracavitary radiofrequency catheter and venous intracavitary radiofrequency generator, which work together to treat lower limb varicose veins caused by superficial venous reflux. The company has signed a distribution agreement with a member company of the BSC Group for the product's sales in the United States. BSC Group will commence commercialization efforts for this product in the U.S. market in due course.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10